2023
Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States
Lee I, Okumura K, Misawa R, Sogawa H, Veillette G, John D, Diflo T, Nishida S, Dhand A. Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States. World Journal Of Hepatology 2023, 15: 554-563. PMID: 37206654, PMCID: PMC10190691, DOI: 10.4254/wjh.v15.i4.554.Peer-Reviewed Original ResearchLiver transplantationHepatocellular carcinomaUnited Network for Organ SharingAlcoholic liver diseaseGraft survivalPathological characteristics of hepatocellular carcinomaMultivariate Cox hazard regression analysisCox hazard regression analysisCharacteristics of hepatocellular carcinomaOutcome of liver transplantationDiagnosis of non-alcoholic steatohepatitisOutcomes of LTSurvival of liver transplantationUnited StatesPost-transplant mortalityField of transplantationDonor risk indexNon-alcoholic steatohepatitisLT recipientsRecipient agePostoperative outcomesInferior outcomesAdult LTRoutine medical careVascular invasionGrading system for medullary thyroid carcinoma; an institutional experience
Podany P, Meiklejohn K, Garritano J, Holt E, Barbieri A, Prasad M, Gilani S. Grading system for medullary thyroid carcinoma; an institutional experience. Annals Of Diagnostic Pathology 2023, 64: 152112. PMID: 36736129, DOI: 10.1016/j.anndiagpath.2023.152112.Peer-Reviewed Original ResearchConceptsMedullary thyroid carcinomaTwo-tier grading systemDistant metastasisNuclear pleomorphismGrading systemNodal diseaseOverall survivalVascular invasionMTC casesThyroid carcinomaMedullary thyroid carcinoma casesMultivariate Cox regressionThyroid carcinoma casesCohort of casesRisk stratificationCox regressionTumor gradePathology reportsCarcinoma casesInstitutional experienceThyroid malignancyTumor fibrosisHG groupProminent nucleoliRare type
2021
Hepatocellular Carcinoma
Jain A, Mazer B, Deng Y, Ciarleglio M, Jain D, Taddei T, Zhang X. Hepatocellular Carcinoma. American Journal Of Clinical Pathology 2021, 157: 305-313. PMID: 34542582, PMCID: PMC12096300, DOI: 10.1093/ajcp/aqab125.Peer-Reviewed Original ResearchConceptsAnaplastic tumor cellsHepatocellular carcinomaNoncirrhotic liverVascular invasionHistologic patternCirrhotic liverTumor cellsClear cell subtypePathogenesis of HCCHigh histologic gradeLarger tumor sizeHigher tumor stageHigh tumor gradeHigh rateHepatitis BHepatitis CLiver diseaseTumor sizeHistologic gradeTumor stageTumor gradePathologic differencesHCC casesRetrospective analysisPathology archives
2018
Calcifying Nested Stromal-Epithelial Tumor of the Liver: An Update and Literature Review
Benedict M, Zhang X. Calcifying Nested Stromal-Epithelial Tumor of the Liver: An Update and Literature Review. Archives Of Pathology & Laboratory Medicine 2018, 143: 264-268. PMID: 30354275, DOI: 10.5858/arpa.2017-0346-rs.Peer-Reviewed Original ResearchConceptsStromal-epithelial tumorStromal tumorsCell tumorsMetastatic gastrointestinal stromal tumorsDesmoplastic small round cell tumorSmall round cell tumorRole of chemotherapyGastrointestinal stromal tumorsCases of metastasisSpindle cell tumorsRound cell tumorMyofibroblastic stromaSurgical interventionSynovial sarcomaTumoral recurrenceVascular invasionRare entityHeterotopic ossificationEpithelial tumorsPsammomatous calcificationEpithelioid cellsTumorsLiverOrganoid arrangementVariety of names
2017
Interobserver Variation among Pathologists and Refinement of Criteria in Distinguishing Separate Primary Tumors from Intrapulmonary Metastases in Lung
Nicholson AG, Torkko K, Viola P, Duhig E, Geisinger K, Borczuk AC, Hiroshima K, Tsao MS, Warth A, Lantuejoul S, Russell PA, Thunnissen E, Marchevsky A, Mino-Kenudson M, Beasley MB, Botling J, Dacic S, Yatabe Y, Noguchi M, Travis WD, Kerr K, Hirsch FR, Chirieac LR, Wistuba II, Moreira A, Chung JH, Chou TY, Bubendorf L, Chen G, Pelosi G, Poleri C, Detterbeck FC, Franklin WA. Interobserver Variation among Pathologists and Refinement of Criteria in Distinguishing Separate Primary Tumors from Intrapulmonary Metastases in Lung. Journal Of Thoracic Oncology 2017, 13: 205-217. PMID: 29127023, PMCID: PMC6276791, DOI: 10.1016/j.jtho.2017.10.019.Peer-Reviewed Original ResearchConceptsSecond primary lung cancerIntrapulmonary metastasesComprehensive histologic assessmentHistologic featuresHistologic patternLung pathologistsHistologic assessmentNuclear pleomorphismMitotic rateSeparate primary tumorsPrimary lung cancerMain histologic typesPredominant patternDistinctive histologic featuresMultiple tumor nodulesClear cell changeRefinement of criteriaLepidic growthHistologic subtypeHistologic typeVascular invasionPrimary tumorLung cancerTumor extentLung tumorsExome analysis of the evolutionary path of hepatocellular adenoma-carcinoma transition, vascular invasion and brain dissemination
Vilarinho S, Erson-Omay E, Mitchell-Richards K, Cha C, Nelson-Williams C, Harmancı AS, Yasuno K, Günel M, Taddei TH. Exome analysis of the evolutionary path of hepatocellular adenoma-carcinoma transition, vascular invasion and brain dissemination. Journal Of Hepatology 2017, 67: 186-191. PMID: 28323122, PMCID: PMC5497691, DOI: 10.1016/j.jhep.2017.03.009.Peer-Reviewed Original ResearchConceptsAdenoma-carcinoma transitionHepatocellular adenomaBrain metastasesHepatocellular carcinomaVascular invasionTumor thrombusCatenin beta 1Rare benign liver tumorMultifocal hepatic lesionsAcute abdominal painBenign liver tumorsPeripheral blood leucocytesSomatic mutationsWhole-exome sequencingParaffin-embedded samplesBrain disseminationAbdominal painLeft hepatectomyMajor complicationsLiver diseaseSpontaneous hemorrhageLeft lobeDisease progressionBlood leucocytesLiver tumors
2016
Clinical implications for imaging of vascular invasion in hepatocellular carcinoma
Baheti AD, Dunham GM, Ingraham CR, Moshiri M, Lall C, Park JO, Li D, Katz DS, Madoff DC, Bhargava P. Clinical implications for imaging of vascular invasion in hepatocellular carcinoma. Abdominal Radiology 2016, 41: 1800-1810. PMID: 27142384, DOI: 10.1007/s00261-016-0763-2.Peer-Reviewed Original ResearchConceptsHepatocellular carcinomaVascular invasionManagement of HCCImportant prognostic factorLimited treatment optionsPromising treatment strategyPrognostic factorsTumor thrombusCancer mortalityTreatment optionsPatient managementTreatment strategiesInterventional radiologistsClinical implicationsLargest causeComprehensive updateCarcinomaInvasionRadiologistsThrombusMajor roleMortalityDiagnosisNTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States
Prasad ML, Vyas M, Horne MJ, Virk RK, Morotti R, Liu Z, Tallini G, Nikiforova MN, Christison-Lagay ER, Udelsman R, Dinauer CA, Nikiforov YE. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States. Cancer 2016, 122: 1097-1107. PMID: 26784937, DOI: 10.1002/cncr.29887.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentCarcinomaCarcinoma, PapillaryChildDNA Mutational AnalysisFemaleHigh-Throughput Nucleotide SequencingHumansMaleMutationNew EnglandNuclear Pore Complex ProteinsOncogene Proteins, FusionProto-Oncogene MasProto-Oncogene ProteinsProto-Oncogene Proteins B-rafProto-Oncogene Proteins c-etsProto-Oncogene Proteins c-retReceptor, trkAReceptor, trkCRepressor ProteinsReverse Transcriptase Polymerase Chain ReactionThyroid Cancer, PapillaryThyroid Neoplasms
2015
Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma
Rezaee N, Barbon C, Zaki A, He J, Salman B, Hruban RH, Cameron JL, Herman JM, Ahuja N, Lennon AM, Weiss MJ, Wood LD, Wolfgang CL. Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma. Hepato Pancreato Biliary 2015, 18: 236-246. PMID: 27017163, PMCID: PMC4814593, DOI: 10.1016/j.hpb.2015.10.010.Peer-Reviewed Original ResearchMeSH KeywordsAgedCarcinoma, Pancreatic DuctalDatabases, FactualDisease-Free SurvivalFemaleHumansKaplan-Meier EstimateLymphatic MetastasisMaleMiddle AgedNeoplasm GradingNeoplasm InvasivenessNeoplasms, Cystic, Mucinous, and SerousNeoplasms, Second PrimaryPancreatectomyPancreatic NeoplasmsProportional Hazards ModelsRisk AssessmentRisk FactorsTime FactorsTreatment OutcomeConceptsIntraductal papillary mucinous neoplasmHigh-grade dysplasiaPancreatic ductal adenocarcinomaNon-invasive intraductal papillary mucinous neoplasmsIntermediate-grade dysplasiaPapillary mucinous neoplasmRemnant pancreasVascular invasionMucinous neoplasmsDuctal adenocarcinomaInvasive pancreatic ductal adenocarcinomaMedian overall survivalLymph node metastasisRate of progressionSubsequent developmentIntermediate dysplasiaPancreatic resectionOverall survivalNode metastasisPerineural invasionMalignant entitiesRisk factorsPatientsDysplasiaPancreasPrognostic Factors in Myoepithelial Carcinoma of Salivary Glands
Kong M, Drill E, Morris L, West L, Klimstra D, Gonen M, Ghossein R, Katabi N. Prognostic Factors in Myoepithelial Carcinoma of Salivary Glands. The American Journal Of Surgical Pathology 2015, 39: 931-938. PMID: 25970687, PMCID: PMC4939272, DOI: 10.1097/pas.0000000000000452.Peer-Reviewed Original ResearchConceptsCa-ex-PAMyoepithelial carcinomaDistant metastasisPrognostic factorsTumor necrosisClinical behaviorVascular invasionPresence of tumor necrosisRate of distant metastasisCarcinoma of salivary glandsCarcinoma ex-pleomorphic adenomaNo distant recurrencesDisease-free survivalMedian Follow-UpEx-pleomorphic adenomaLymph node metastasisDistant recurrenceLocal recurrencePositive marginsRare tumorPerineural invasionPathology filesAggressive tumorsNode metastasisClinical outcomesEmerging trends in hepatocellular carcinoma incidence and mortality
Njei B, Rotman Y, Ditah I, Lim JK. Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology 2015, 61: 191-199. PMID: 25142309, PMCID: PMC4823645, DOI: 10.1002/hep.27388.Peer-Reviewed Original ResearchConceptsIB mortalityHCC incidenceHepatocellular carcinomaIncidence of HCCMultivariable Cox regression analysisOverall median survivalCox regression analysisEnd Results (SEER) dataSignificant survival improvementAge-adjusted incidenceU.S. populationHepatocellular carcinoma incidenceJoinpoint Regression ProgramIncidence-based mortalityRegression analysisSignificant increaseCurative modalityLiver transplantCurative stageMedian survivalSurvival improvementCarcinoma incidenceTumor sizeVascular invasionPrimary tumor
2012
Significance of CEACAM6 expression in biliary tract carcinoma.
Rocha F, Torres J, Chou J, Katabi N, Gönen M, DeMatteo R, Fong Y, Allen P, D'Angelica M, Klimstra D, Jarnagin W. Significance of CEACAM6 expression in biliary tract carcinoma. Journal Of Clinical Oncology 2012, 30: 207-207. DOI: 10.1200/jco.2012.30.4_suppl.207.Peer-Reviewed Original ResearchDisease-specific survivalBile duct carcinomaCEACAM6 expressionDuct carcinomaTissue microarrayVascular invasionIntrahepatic cholangiocarcinomaAssociated with disease-specific survivalCases of bile duct carcinomaParaffin-embedded surgical specimensAssociated with age >Marker of poor outcomeAssociated with poor prognosisBiliary tract carcinomaPositive lymph nodesControl tissuesHigher T stageKaplan-Meier methodMultivariable proportional hazards regressionLog-rank testPredictors of survivalProportional hazards regressionHilar tumorsR0 resectionIntrahepatic tumorsCarcinoma Ex Microcystic Adenoma of the Pancreas
Zhu H, Qin L, Zhong M, Gordon R, Raoufi M, Hechtman J, Schwartz M, Roayaie S, Klimstra D. Carcinoma Ex Microcystic Adenoma of the Pancreas. The American Journal Of Surgical Pathology 2012, 36: 305-310. PMID: 22189969, DOI: 10.1097/pas.0b013e3182393dc3.Peer-Reviewed Original ResearchConceptsMicrocystic serous cystadenomaSerous cystadenomaSerous cystic tumorsBenign serous cystadenomaSignet ring-like cellsDiagnosis of malignancySerous cystic neoplasmsMetachronous metastasesCystic tumorMalignant counterpartsBenign lesionsSolid nestsCystic neoplasmsLymph nodesVascular invasionAdjacent organsMicrocystic adenomaHistological featuresMalignant neoplasmsTumor invasionCystadenomaUnique caseCuboidal cellsCarcinomaNeoplasmsComparison of hepatocellular carcinoma in American and Asian patients by tissue array analysis
Song T, Fong Y, Cho S, Gönen M, Hezel M, Tuorto S, Choi S, Kim Y, Suh S, Koo B, Chae Y, Jarnagin W, Klimstra D. Comparison of hepatocellular carcinoma in American and Asian patients by tissue array analysis. Journal Of Surgical Oncology 2012, 106: 84-88. PMID: 22234941, PMCID: PMC3346847, DOI: 10.1002/jso.23036.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAsian PeopleBiomarkers, TumorCarcinoma, HepatocellularCyclin D1Cyclin-Dependent Kinase Inhibitor p21FemaleGene Expression Regulation, NeoplasticHepatitis BHepatitis CHumansImmunohistochemistryKi-67 AntigenLiver NeoplasmsLymphatic MetastasisMaleMiddle AgedNeoplasm InvasivenessParaffinPrognosisProliferating Cell Nuclear AntigenProto-Oncogene Proteins c-bcl-2Proto-Oncogene Proteins c-mdm2Republic of KoreaRisk FactorsTissue Array AnalysisTumor Suppressor Protein p53United StatesConceptsHepatocellular carcinomaKorea University Medical CenterMolecular pathogenesis of hepatocellular carcinomaMolecular targeted therapyViral hepatitis infectionWestern hepatocellular carcinomaMarkers of proliferationTissue array analysisPathogenesis of hepatocellular carcinomaComparisons of hepatocellular carcinomaExpression of Ki67Expression of p53University Medical CenterMDM2 stainingMicroarray sectionsNo significant differenceAsian patientsTissue microarrayVascular invasionHepatitis infectionImmunohistochemical stainingPositive stainingRegulation of cell cycleHCC specimensPathologic correlation
2011
Factors affecting lymphovascular invasion in node-positive breast cancer patients.
Cornwell L, McMasters K, Chagpar A. Factors affecting lymphovascular invasion in node-positive breast cancer patients. Journal Of Clinical Oncology 2011, 29: 24-24. DOI: 10.1200/jco.2011.29.27_suppl.24.Peer-Reviewed Original ResearchBreast cancer patientsLVI positivityCancer patientsExtracapsular extensionLarge tumorsNode-positive breast cancer patientsPositive lymph nodesProportion of patientsCohort of patientsPoor prognostic factorProspective multicenter studySynoptic pathology reportsBreast cancer tumorsBreast practicePositive nodesLarge metastasesLymphovascular invasionPatient agePrognostic factorsSurgery typeClinicopathologic factorsLymph nodesMulticenter studyVascular invasionPathology reports
2010
Prognostic Impact of Muscular Venous Branch Invasion in Localized Renal Cell Carcinoma Cases
Feifer A, Savage C, Rayala H, Lowrance W, Gotto G, Sprenkle P, Gupta A, Taylor J, Bernstein M, Adeniran A, Tickoo SK, Reuter VE, Russo P. Prognostic Impact of Muscular Venous Branch Invasion in Localized Renal Cell Carcinoma Cases. Journal Of Urology 2010, 185: 37-42. PMID: 21074196, PMCID: PMC3437930, DOI: 10.1016/j.juro.2010.08.084.Peer-Reviewed Original ResearchConceptsRenal vein invasionRenal cell carcinoma casesVein invasionInvasion groupCarcinoma casesCareful pathological assessmentMultivariate Cox modelOverall survival rateAmerican Joint CommitteeCancer (AJCC) staging systemRisk of recurrencePrognostic equivalencePrognostic impactTumor characteristicsAdverse prognosisRadical nephrectomyRecurrence rateVascular invasionStaging systemNephrectomy specimenPathological assessmentCox modelPatientsJoint CommitteeSurvival ratePrognostic factors of recurrence in salivary carcinoma ex pleomorphic adenoma, with emphasis on the carcinoma histologic subtype: a clinicopathologic study of 43 cases
Katabi N, Gomez D, Klimstra D, Carlson D, Lee N, Ghossein R. Prognostic factors of recurrence in salivary carcinoma ex pleomorphic adenoma, with emphasis on the carcinoma histologic subtype: a clinicopathologic study of 43 cases. Human Pathology 2010, 41: 927-934. PMID: 20338616, DOI: 10.1016/j.humpath.2009.12.011.Peer-Reviewed Original ResearchConceptsDisease-free survivalDecreased disease-free survivalDisease-specific survivalPleomorphic adenomaMyoepithelial carcinomaHistological subtypesInvasive carcinomaInvasive tumorsVascular invasionMitotic ratePrognostic factors of recurrenceRare salivary gland neoplasmSalivary duct carcinomaFactors of recurrenceSalivary gland neoplasmsRisk of recurrenceCases of carcinomaAdequate follow-upBehavior of carcinomaPleomorphic adenoma groupMetastatic diseaseDistant metastasisMalignant componentPrognostic factorsSalivary carcinomasHistopathologic Basis for the Favorable Survival after Resection of Intraductal Papillary Mucinous Neoplasm-Associated Invasive Adenocarcinoma of the Pancreas
Poultsides GA, Reddy S, Cameron JL, Hruban RH, Pawlik TM, Ahuja N, Jain A, Edil BH, Iacobuzio-Donahue CA, Schulick RD, Wolfgang CL. Histopathologic Basis for the Favorable Survival after Resection of Intraductal Papillary Mucinous Neoplasm-Associated Invasive Adenocarcinoma of the Pancreas. Annals Of Surgery 2010, 251: 470-476. PMID: 20142731, PMCID: PMC3437748, DOI: 10.1097/sla.0b013e3181cf8a19.Peer-Reviewed Original ResearchConceptsIntraductal papillary mucinous neoplasmPancreatic ductal adenocarcinomaResection of IPMNsAdverse pathologic characteristicsInvasive pancreatic adenocarcinomaAdvanced T stageLymph node metastasisInvasive adenocarcinomaPancreatic adenocarcinomaFavorable survivalNode metastasisPathologic characteristicsT stageVascular invasionRegional lymph node metastasisFavorable biologic behaviorMicroscopic margin involvementPancreatic resection databasePositive resection marginsCox regression analysisHigh tumor gradePapillary mucinous neoplasmPoor tumor differentiationCurative intentMargin involvementPrognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma
Shin W, Suh K, Lee H, Kim J, Kim T, Yi N, Lee K. Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma. Liver Transplantation 2010, 16: 678-684. PMID: 20440777, DOI: 10.1002/lt.22047.Peer-Reviewed Original ResearchConceptsAdult Living Donor Liver TransplantationDonor liver transplantationHepatocellular carcinomaPrognostic factorsLiver transplantationUnresectable diseaseBony metastasesMultiorgan involvementVascular invasionAlpha-fetoprotein level >Multivariate analysisMedian time to recurrenceRecurrent hepatocellular carcinomaTime to recurrenceEarly hepatocellular carcinomaMedian survival timeSurgical resectionRecurrent lesionsGood prognosisShorter survivalAdult patientsUnivariate analysisFollow-upAppropriate treatmentRecurrence
2008
Pancreatic Resection of Isolated Metastases from Nonpancreatic Primary Cancers
Reddy S, Edil BH, Cameron JL, Pawlik TM, Herman JM, Gilson MM, Campbell KA, Schulick RD, Ahuja N, Wolfgang CL. Pancreatic Resection of Isolated Metastases from Nonpancreatic Primary Cancers. Annals Of Surgical Oncology 2008, 15: 3199-3206. PMID: 18784960, DOI: 10.1245/s10434-008-0140-7.Peer-Reviewed Original ResearchConceptsRenal cell carcinomaPancreatic resectionMetachronous lesionsMetastatic lesionsVascular invasionConclusionLong-term survivalResultsForty-nine patientsLymph node metastasisLangerhans cell histiocytosisDistal pancreatectomyPerioperative deathsPostoperative morbidityTotal pancreatectomyIsolated metastasisMedian survivalMetastatic diseaseSynchronous lesionsNode metastasisPrimary diseasePrimary cancerMedian lengthCell carcinomaGallbladder cancerSingle institutionCell histiocytosis
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply